The CDC’s Advisory Committee on Immunization Practices (ACIP) has blessed Merck’s new respiratory syncytial virus (RSV) shot Enflonsia, but the decision was hardly resounding from Robert F. | The ...

The newly appointed vaccine advisory panel for the Centers for Disease Control and Prevention (CDC) met Wednesday for the first time to review upcoming immunization recommendations.

U.S. Health Secretary Robert F. Kennedy Jr.'s newly revamped vaccine advisory panel voted on Thursday for recommending use of ...

A group of outside advisers to the U.S. Centers for Disease Control and Prevention voted 5-2 to recommend the use of a new shot that can protect babies from respiratory syncytial virus, adding an ...

Robert F. Kennedy Jr. fired the previous 17-member panel this month and replaced it with a seven-member group that includes ...

The newly formed Advisory Committee on Immunization Practices has voted 5-2 to recommend Merck’s respiratory syncytial virus monoclonal antibody drug, clesrovimab, for infants younger than 8 months.

A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...

The votes in favor of Merck’s shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom ...

Robert F. Kennedy's handpicked seven-member panel will evaluate the “cumulative effect” of the children’s vaccine schedule, ...

A group of outside advisers to the US Centers for Disease Control and Prevention voted 5-2 to recommend use of a new shot ...

Federal vaccine advisors on Thursday recommended Merck's new RSV antibody shot for infants younger than eight months old in ...